JLJessica G. Y. Luc

Jessica G. Y. Luc

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jessica G. Y. Luc has a total of 553 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Management Strategies for Descending Thoracic Aortic Thrombus: A Review of the Literature

    by Quynh Nguyen, Xiya Ma, Dominique Vervoort, Jessica G. Y. Luc

    Descending thoracic aortic thrombus (DTAT) is an under-recognized source of systemic emboli with potential catastrophic consequences. Imaging modalities such as echocardiography, computed tomography, magnetic resonance imaging, and angiography can help identify and characterize the extent of embolic events. Established guidelines regarding the management of DTAT are currently lacking. Multiple treatment modalities are available; however, the effectiveness of each approach remains to be determined. In this study, we performed a review to examine the clinical presentation, diagnostic methods and findings, and outcomes of various treatment options for patients with DTAT. Medical management is the least invasive and most frequently chosen initial approach, offering a high reported success rate, whereas endovascular therapy can have a role in thrombus exclusion should conservative management fail.


  • Open Access

    Transcatheter Versus Surgical Aortic Valve Replacement in Young, Low-risk Patients with Severe Aortic Stenosis

    by Quynh Nguyen, Jessica Gy Luc, Thomas E MacGillivray, Ourania A Preventza

    Aortic stenosis is a common form of acquired degenerative valvular disease associated with poor survival after the onset of symptoms. Treatment options for patients with aortic stenosis in addition to medical therapy include surgical aortic valve replacement (SAVR) with either tissue or mechanical valves, or transcatheter aortic valve replacement (TAVR) with either balloon-expandable or self-expanding valves via either transfemoral or alternative access routes. In this review, the authors discuss the current evidence and special considerations regarding the use of TAVR versus SAVR in the management of severe aortic stenosis in young (<65 years of age), low-risk patients, highlighting the history of aortic stenosis treatment, the current guidelines and recommendations, and important issues that remain to be addressed. Ultimately, until ongoing clinical trials with long-term follow-up data shed light on whether interventions for aortic stenosis can be broadened to a low-risk population, TAVR in young, low-risk patients should be undertaken with caution and with guidance from a multidisciplinary heart team.


  • What Makes Surgical Ethics Unique?

    by Jessica G. Y. Luc, Jason J. Han, Robert M. Sade

  • Exploring differences in perceptions around Social Media Competencies: An Expert vs. Frontline User Study

    by Yusuf Yilmaz, Puru Panchal, Jessica G. Y. Luc, Ali Raja, Brent Thoma, Faiza Khokhar, Mary Haas, Natalie Anderson, Teresa M. Chan

    Aim: Scholarly communities increasingly interact using social media (SoMe). This study investigated curricular expectations of expert and frontline SoMe users, with the goal of identifying differences that might inform the development of a curriculum designed to teach clinicians and researchers the effective use of SoMe.Methods: From May 15 to August 28, 2020, we recruited participants via the METRIQ study recruitment protocol. Participants were stratified into “expert” and “frontline” users based on prior experience with SoMe. “Expert” users were defined as having published SoMe research, run SoMe workshops, or through the use of a popular #SoMe account. All others were categorized as “frontline” users. Participants completed a 14-question survey (with 90 sub-questions) regarding the content, skills, and attitudes that they believed should be taught to educators or researchers new to SoMe.Results: In total, 224 users were invited, and 184 users filled out the survey. Experts were more likely to recommend teaching clinicians to use blogs (88% vs 74%), Facebook (46% vs 32%), Instagram (51% vs 34%), Medium (16% vs 4%), Snapchat (15% vs 4%), TikTok (29% vs 12%), and Twitter (97% vs 88%) compared to frontline users. Experts were more likely to recommend SoMe to foster communities of practice (83% vs 66%), disseminate research (80% vs 67%), and promote engagement for knowledge translation (86% vs 74%) compared to frontline users. Conclusions: There are few differences between the SoMe curricular expectations of expert vs. frontline users. These results could inform the creation of resources for teaching clinicians and researchers how to effectively use SoMe.


  • Open Access

    COVID‐19 and cardiothoracic surgery: Effects on training and workforce utilization in a global pandemic

    by Benjamin Smood, John R. Spratt, J. Hunter Mehaffey, Jessica G. Y. Luc, Eric E. Vinck, Miia L. Lehtinen, Tyler J. Wallen, Charles G. Jenkinson, Woojung Kim, Emeka B. Kesieme, et al.

    Background The COVID-19 pandemic has disrupted all aspects of healthcare, including cardiothoracic surgery (CTS). We sought to determine the pandemic's impact on CTS trainees' educational experiences. Methods A survey was developed and distributed to members of the Thoracic Surgery Residents Association and other international CTS trainees. Trainees were asked to evaluate their cumulative experiences and share their overall perceptions of how CTS training had been impacted during the earliest months of the COVID-19 pandemic (i.e., since March 01, 2020). Surveys were distributed and responses were recorded June 25–August 05, 2020. In total, 748 surveys were distributed and 166 responses were received (overall response rate 22.2%). Of these, 126 of 166 responses (75.9%) met inclusion criteria for final analysis. Results Final responses analyzed included 45 of 126 (35.7%) United States (US) and 81 of 126 (64.3%) international trainees, including 101 of 126 (80.2%) senior and 25 of 126 (19.8%) junior trainees. Most respondents (76/126, 43.2%) lost over 1 week in the hospital due to the pandemic. Juniors (12/25, 48.0%) were more likely than seniors (20/101, 19.8%) to be reassigned to COVID-19-specific units (p < .01). Half of trainees (63/126) reported their case volumes were reduced by over 50%. US trainees (42/45, 93.3%) were more likely than international trainees (58/81, 71.6%) to report reduced operative case volumes (p < .01). Most trainees (104/126, 83%) believed their overall clinical acumen was not adversely impacted by the pandemic. Conclusions CTS trainees in the United States and abroad have been significantly impacted by the COVID-19 pandemic, with time lost in the hospital, decreased operative experiences, less time on CTS services, and frequent reassignment to COVID-19-specific care settings.


  • Ticagrelor use and practice patterns among Canadian cardiac surgeons

    by Ahmad Makhdoum, Nitish K. Dhingra, Aathmika Kirubaharan, Rachel Eikelboom, Jessica Luc, Olina Dagher, Joel Bierer, Andreanne Cartier, Olivier Vaillancourt, Thin X. Vo, et al.

    Background and Aim The P2Y12 platelet receptor inhibitor ticagrelor is widely used in patients following acute coronary syndromes or in those who have received coronary stents. Bentracimab is a monoclonal antibody-based reversal agent that is being formally evaluated in a Phase 3 clinical trial. Here, we probe the knowledge, attitudes, and practice patterns of cardiac surgeons regarding their perioperative management of ticagrelor and potential application of a ticagrelor reversal agent. Methods A questionnaire was developed by a working group of cardiac surgeons to inquire into participants’ practices and beliefs regarding ticagrelor and disseminated to practicing, Canadian-trained cardiac surgeons. Results A total of 70 Canadian-trained cardiac surgeons participated. Bleeding risk was identified as the most significant consideration when surgically revascularizing ticagrelor-treated patients (90%). There is variability in the duration of withholding ticagrelor before coronary artery bypass graft procedure in a stable patient; 44.3% wait 3 days and 32.9% wait 4 days or longer. Currently, 15.7% of cardiac surgeons prophylactically give platelet transfusions and fresh frozen plasma intraoperatively following protamine infusion in patients who have recently received ticagrelor. Interestingly, 47.1% of surveyed surgeons were aware of a reversal agent for ticagrelor, 91.4% of cardiac surgeons would consider utilizing a ticagrelor reversal agent if available, and 51.4% acknowledged that the introduction of such an agent would be a major advance in clinical practice. Conclusions The present survey identified ticagrelor-related bleeding as a major concern for cardiac surgeons. Surgeons recognized the significant unmet need that a ticagrelor reversal agent would address.


  • Intersection of Race and Gender in Surgical Training

    by Hiba Ghandour, Jessica G. Y. Luc

    To the Editor We applaud Mocanu et al1 for highlighting the importance of an intersectional approach to gender and race among general surgery residents. Knowledge about women and those of visible minority (VM) status in surgery is vital to ensure a comprehensive approach toward equity for all. This article draws an association between gender, VM status, and resiliency. However, we respectfully assert that beyond defining trainees as “at-risk residents”1 for an adverse training experience based on their gender and VM status, the focus should be not on the nonmodifiable factors of a trainee, but on the modifiable ones, such as cultural issues and barriers, as well as implicit and explicit biases. Identify all potential conflicts of interest that might be relevant to your comment. Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. Err on the side of full disclosure. If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response. Not all submitted comments are published. Please see our commenting policy for details.